Single-Time-Point Time-integrated Activity Estimation for Dosimetry in 177Lu-PSMA Therapy: Evaluation of Analytical and Machine Learning Methods

BACKGROUND: The routine clinical implementation of patient-specific dosimetry in 177Lu-PSMA radiopharmaceutical therapy can be challenging due to the need for multiple-time-point posttherapy SPECT/CT imaging to estimate time-integrated activity (TIA). Single-time-point (STP) approaches offer a more practical alternative, although their accuracy has yet to be fully established. This study aimed to evaluate existing analytical STP methods and to assess the feasibility and performance of a machine learning (ML) framework. PATIENTS AND METHODS: Thirty-four patients with metastatic castration-resistant prostate cancer undergoing 177Lu-PSMA-617 therapy were retrospectively analyzed. Reference TIAs were derived from multiple-time-point 177Lu SPECT/CT imaging at 3 or 4 time points (TPs) postinjection (TP1: 0.7-2.1 h, TP2: day 1-2, TP3: day 3-4, TP4: day 5-7) in cycle 1 for 147 tumors, 64 kidneys, and 65 parotid glands using monoexponential or biexponential fitting. Analytical STP methods, proposed by Hänscheid and Madsen, were evaluated across different TPs. For each organ, a ML model was developed using a residual learning approach, in which the log-transformed ratio between reference TIAs and analytical STP TIA estimates was modeled. Input features included combinations of STP SPECT-derived parameters, baseline 68Ga-PSMA-11 PET-derived biomarkers (for individual structures and whole-body tumor volume), and clinical variables. Model performance was evaluated by using multiple quantitative metrics within a 10-times repeated 5-fold nested cross-validation framework and compared with purely analytic STP approaches. Model interpretability was assessed using SHapley Additive exPlanations. RESULTS: Analytical methods showed strong performance at optimal imaging TPs (TP2 for kidney/parotid, and TP3 for tumor), with the largest errors observed at early imaging (TP1). Overall, ML models provided modest improvement over analytical methods across structures at most TPs. The best performance was achieved using a ML model combining PET/SPECT imaging features with analytical TIA estimates. The mean percentage errors of the models, across TPs, ranged from -1.7 ± 17.9% (TP2) to 7.4 ± 65.3% (TP1) for kidneys, -0.4 ± 12.1% (TP2) to 4.5 ± 26.7% (TP4) for parotid glands, and 1.4 ± 14.8% (TP3) to -4.1 ± 100.5% (TP1) for tumors. Within the present cohort and modeling framework, the inclusion of clinical variables did not significantly improve model performance. SHapley Additive exPlanations analysis showed that the ML models applied a positive correction to the analytical TIA estimates at early imaging TPs and a negative correction at late TPs. CONCLUSIONS: Analytical STP methods yield accurate TIA estimates when applied at appropriate imaging TPs. ML models that integrate analytical estimates with imaging features provide modest improvements in accuracy with less sensitivity to TP selection. However, optimal timing remained structure-dependent, requiring a compromise when a single acquisition is used. These findings support the potential of ML-driven STP dosimetry in 177Lu-PSMA-617 radiopharmaceutical therapy to enable more flexible and clinically feasible workflows, pending further validation with larger and more diverse data sets.

Authors

Institutions

Publication Details

Journal
Clinical Nuclear Medicine
Published
2026-11-18
DOI
https://doi.org/10.1097/rlu.0000000000006766
Primary Topic
Radiopharmaceutical Chemistry and Applications
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Single-Time-Point Time-integrated Activity Estimation for Dosimetry in 177Lu-PSMA Therapy: Evaluation of Analytical and Machine Learning Methods

Habib Zaidi, Ka Kit Wong, Krithika Suresh, Kellen Fitzpatrick et al.
2 links
Clinical Nuclear Medicine
Radiopharmaceutical Chemistry and Applications
article

Single-Time-Point Time-integrated Activity Estimation for Dosimetry in 177Lu-PSMA Therapy: Evaluation of Analytical and Machine Learning Methods

Habib Zaidi, Ka Kit Wong, Krithika Suresh, Kellen Fitzpatrick, Molly E Roseland, Yuni K. Dewaraja, Zahra Mansouri, Madeline Fredericks
article en

Abstract

BACKGROUND: The routine clinical implementation of patient-specific dosimetry in 177Lu-PSMA radiopharmaceutical therapy can be challenging due to the need for multiple-time-point posttherapy SPECT/CT imaging to estimate time-integrated activity (TIA). Single-time-point (STP) approaches offer a more practical alternative, although their accuracy has yet to be fully established. This study aimed to evaluate existing analytical STP methods and to assess the feasibility and performance of a machine learning (ML) framework. PATIENTS AND METHODS: Thirty-four patients with metastatic castration-resistant prostate cancer undergoing 177Lu-PSMA-617 therapy were retrospectively analyzed. Reference TIAs were derived from multiple-time-point 177Lu SPECT/CT imaging at 3 or 4 time points (TPs) postinjection (TP1: 0.7-2.1 h, TP2: day 1-2, TP3: day 3-4, TP4: day 5-7) in cycle 1 for 147 tumors, 64 kidneys, and 65 parotid glands using monoexponential or biexponential fitting. Analytical STP methods, proposed by Hänscheid and Madsen, were evaluated across different TPs. For each organ, a ML model was developed using a residual learning approach, in which the log-transformed ratio between reference TIAs and analytical STP TIA estimates was modeled. Input features included combinations of STP SPECT-derived parameters, baseline 68Ga-PSMA-11 PET-derived biomarkers (for individual structures and whole-body tumor volume), and clinical variables. Model performance was evaluated by using multiple quantitative metrics within a 10-times repeated 5-fold nested cross-validation framework and compared with purely analytic STP approaches. Model interpretability was assessed using SHapley Additive exPlanations. RESULTS: Analytical methods showed strong performance at optimal imaging TPs (TP2 for kidney/parotid, and TP3 for tumor), with the largest errors observed at early imaging (TP1). Overall, ML models provided modest improvement over analytical methods across structures at most TPs. The best performance was achieved using a ML model combining PET/SPECT imaging features with analytical TIA estimates. The mean percentage errors of the models, across TPs, ranged from -1.7 ± 17.9% (TP2) to 7.4 ± 65.3% (TP1) for kidneys, -0.4 ± 12.1% (TP2) to 4.5 ± 26.7% (TP4) for parotid glands, and 1.4 ± 14.8% (TP3) to -4.1 ± 100.5% (TP1) for tumors. Within the present cohort and modeling framework, the inclusion of clinical variables did not significantly improve model performance. SHapley Additive exPlanations analysis showed that the ML models applied a positive correction to the analytical TIA estimates at early imaging TPs and a negative correction at late TPs. CONCLUSIONS: Analytical STP methods yield accurate TIA estimates when applied at appropriate imaging TPs. ML models that integrate analytical estimates with imaging features provide modest improvements in accuracy with less sensitivity to TP selection. However, optimal timing remained structure-dependent, requiring a compromise when a single acquisition is used. These findings support the potential of ML-driven STP dosimetry in 177Lu-PSMA-617 radiopharmaceutical therapy to enable more flexible and clinically feasible workflows, pending further validation with larger and more diverse data sets.

Clinical Nuclear Medicine
University of Groningen (NL), University of Southern Denmark (DK), University of Michigan (US), University Hospital of Geneva (CH)
Good health and well-being
Radiopharmaceutical Chemistry and Applications
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon